National News
NAFDAC halts Artemether/Lumefantrine registration
The National Agency for Food and Drug Administration and Control (NAFDAC) has halted the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension.
The announcement was made in a public alert No. 01/2025, released on the agency’s website yesterday.
NAFDAC explained that the decision was made due to the instability of the reconstituted formulations, which could lead to a loss of efficacy over time.
According NAFDAC, the suspension applies to all locally manufactured and imported Multi-Dose Artemether/Lumefantrine dry powder for oral use.
“NAFDAC will no longer accept new applications, renewals, or variations for this product.”
According to the Agency, stability studies revealed that reconstituted Artemether/Lumefantrine oral suspension becomes unstable after mixing, leading to a loss
Ifeoma Nwovu
-
Sports1 day agoInfantino fires back at World Cup critics, says FIFA delivered ‘Only Joy and Happiness’
-
News1 day agoTroops foil terrorist attack on military base, rescue 21 female students in Borno
-
Sports21 hours agoWAFCON 2026: Super Falcons begin title defence against debutants Malawi
-
World News1 day agoIran not in negotiations with US despite ceasefire, foreign ministry says
-
News1 day agoI’ll serve only one term if elected President — Peter Obi
-
News1 day agoHoodlums invade Osun PVC distribution centre, cart away voter cards
-
National News1 day agoFG approves 35% hazard allowance increase for NASU members in federal universities
-
News22 hours agoReps panel orders IGP to produce PFIPC DG within 48 Hours over probe






